The choice of test in phase II cancer trials assessing continuous tumour shrinkage when complete responses are expected. (2015)

First Author: Wason JM
Attributed to:  Hub in Trials Methodology Research (MRC Biostatistics Unit, Cambridge) funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1177/0962280211432192

PubMed Identifier: 22179821

Publication URI: http://europepmc.org/abstract/MED/22179821

Type: Journal Article/Review

Volume: 24

Parent Publication: Statistical methods in medical research

Issue: 6

ISSN: 0962-2802